Skip to content
329 Tags

Ketamine Topics

Browse Ketamine Resource articles by topic.

definition23esketamine20mental health20treatment-resistant depression19ketamine therapy15neuroscience15Spravato14glutamate10ketamine10comparison9depression treatment9treatment9TRD8bioavailability8FDA7pharmacology7safety7telehealth7clinical trials6depression6dosing6patient education6research6side effects620255NMDA5Treatment-Resistant Depression5administration5cost5insurance5ketamine research5neuroplasticity5prescribing5remission5DEA4Esketamine4IV infusion4Ketamine Therapy4at-home ketamine4clinical research4enantiomer4faq4guide4mechanism4regulation4regulations4suicidal ideation4treatment methods4treatment-resistant-depression4BDNF3Clinical Research3IV ketamine3Mental Health3access3antidepressants3clinical protocols3contraindications3dissociation3enantiomers3ketamine methods3measurement-based care3nasal spray3pharmacokinetics3policy3risks3timeline3treatment method3DMN2GAD2PTSD2Patient Experience2SSRIs2Side Effects2affordability2antidepressant2anxiety2arketamine2at-home2brain2chronic pain2clinical context2compounded ketamine2conditions2coverage2default mode network2education2financial assistance2formulations2history2insurance coverage2intramuscular2intranasal2ketamine alternatives2ketamine glossary2ketamine news2ketamine resource2mTOR2mechanism of action2mechanism-of-action2mental health policy2mental health research2metabolism2neuroimaging2neuroinflammation2neurotransmitter2norketamine2oral2oral-ketamine2overview2patient experience2patient safety2pricing2psychiatry2rumination2social anxiety2sublingual2synapses2synaptogenesis2treatment routes220261AMPA receptor1Acute Stress1Alternative Treatments1BPL-0031BXCL5011CBT1CFS1CRPS1Clinical Best Practices1Clinical Care1Clinical Trials1DNA-methylation1Depression Treatment1ECT1GABA1GP referral1IM ketamine1IV Ketamine1IV-ketamine1KAP1ME1Mental Health Research1NMDA antagonists1Nevada1OCD1Patient Safety1R-ketamine1Remission1Ryan-Haight-Act1S-ketamine1SNRI1SSRI1Schedule III1TMS1absorption1access to care1addiction1administration routes1alcohol use disorder1anesthesia1anti-inflammatory1approval1atai life sciences1best-practices1bipolar1bipolar depression1blood pressure1brain circuits1brain networks1candidates1chirality1chronic-fatigue-syndrome1clinic access1clinic-standards1clinical care1clinical guidance1clinical management1clinical studies1clinical terms1clinical treatment1combination therapy1companies1compounding1compounding pharmacy1compounding-pharmacy1continuous infusion1controlled-substance1credentials1crisis intervention1cytokines1definitions1deprescribing1depression-treatment1developments1diagnosis1direct-to-consumer1dose optimization1drug development1drug-interactions1duration1effects1electroconvulsive-therapy1eligibility1emergency psychiatry1emerging treatments1epigenetics1excitatory1excitatory-neurotransmission1experience1fibromyalgia1finding treatment1first-pass-metabolism1first-visit1gene-expression1getting-started1global1glutamatergic-system1guidelines1healthcare1hearing1histone-modification1industry1infusion1inhibitory1injection1inpatient1integration1international1interventional psychiatry1ketamine clinic1ketamine cost1ketamine experience1ketamine infusion1ketamine policy1ketamine regulation1ketamine safety1ketamine treatment1ketamine-assisted therapy1ketamine-therapy1legal1long-term treatment1lozenges1maintenance1major depression1medical conference1mental health access1metabolite1methods1microglia1mindset1monitoring1mood disorders1nasal ketamine1nausea1neuropathic pain1neurotrophic factor1new research1nonprofit1obsessive-compulsive disorder1opioid addiction1opioid-receptors1opioid-system1oral ketamine1outcomes1palliative-care1panic disorder1patient guide1patient-safety1pediatric1pharmacy1phase III1plain language1prior authorization1private clinics1program expansion1protein-synthesis1protocol1provider1provider choice1provider selection1psilocybin1psychedelic medicine1psychedelic therapy1psychedelic-therapy1psychiatric care1psychoactive effects1psychotherapy1quality1racemic ketamine1racemic-ketamine1racemic-mixture1rapid-acting antidepressants1receptor1rectal1relapse prevention1repeated use1research terms1risk1routes-of-administration1schedule-III1science1screening1sensitization1serotonin1serotonin-syndrome1set and setting1side-effects1state law1stereochemistry1sub-anesthetic-dose1sublingual ketamine1substance use disorders1suicide prevention1supervision1synaptic-growth1telehealth ketamine1therapeutic framework1therapy1tinnitus1tolerance1topical1transcranial-magnetic-stimulation1trauma1treatment access1treatment comparison1treatment considerations1treatment environment1treatment-resistant conditions1troches1

All Tags

definition23 articlesesketamine20 articlesmental health20 articlestreatment-resistant depression19 articlesketamine therapy15 articlesneuroscience15 articlesSpravato14 articlesglutamate10 articlesketamine10 articlescomparison9 articlesdepression treatment9 articlestreatment9 articlesTRD8 articlesbioavailability8 articlesFDA7 articlespharmacology7 articlessafety7 articlestelehealth7 articlesclinical trials6 articlesdepression6 articlesdosing6 articlespatient education6 articlesresearch6 articlesside effects6 articles20255 articlesNMDA5 articlesTreatment-Resistant Depression5 articlesadministration5 articlescost5 articlesinsurance5 articlesketamine research5 articlesneuroplasticity5 articlesprescribing5 articlesremission5 articlesDEA4 articlesEsketamine4 articlesIV infusion4 articlesKetamine Therapy4 articlesat-home ketamine4 articlesclinical research4 articlesenantiomer4 articlesfaq4 articlesguide4 articlesmechanism4 articlesregulation4 articlesregulations4 articlessuicidal ideation4 articlestreatment methods4 articlestreatment-resistant-depression4 articlesBDNF3 articlesClinical Research3 articlesIV ketamine3 articlesMental Health3 articlesaccess3 articlesantidepressants3 articlesclinical protocols3 articlescontraindications3 articlesdissociation3 articlesenantiomers3 articlesketamine methods3 articlesmeasurement-based care3 articlesnasal spray3 articlespharmacokinetics3 articlespolicy3 articlesrisks3 articlestimeline3 articlestreatment method3 articlesDMN2 articlesGAD2 articlesPTSD2 articlesPatient Experience2 articlesSSRIs2 articlesSide Effects2 articlesaffordability2 articlesantidepressant2 articlesanxiety2 articlesarketamine2 articlesat-home2 articlesbrain2 articleschronic pain2 articlesclinical context2 articlescompounded ketamine2 articlesconditions2 articlescoverage2 articlesdefault mode network2 articleseducation2 articlesfinancial assistance2 articlesformulations2 articleshistory2 articlesinsurance coverage2 articlesintramuscular2 articlesintranasal2 articlesketamine alternatives2 articlesketamine glossary2 articlesketamine news2 articlesketamine resource2 articlesmTOR2 articlesmechanism of action2 articlesmechanism-of-action2 articlesmental health policy2 articlesmental health research2 articlesmetabolism2 articlesneuroimaging2 articlesneuroinflammation2 articlesneurotransmitter2 articlesnorketamine2 articlesoral2 articlesoral-ketamine2 articlesoverview2 articlespatient experience2 articlespatient safety2 articlespricing2 articlespsychiatry2 articlesrumination2 articlessocial anxiety2 articlessublingual2 articlessynapses2 articlessynaptogenesis2 articlestreatment routes2 articles20261 articleAMPA receptor1 articleAcute Stress1 articleAlternative Treatments1 articleBPL-0031 articleBXCL5011 articleCBT1 articleCFS1 articleCRPS1 articleClinical Best Practices1 articleClinical Care1 articleClinical Trials1 articleDNA-methylation1 articleDepression Treatment1 articleECT1 articleGABA1 articleGP referral1 articleIM ketamine1 articleIV Ketamine1 articleIV-ketamine1 articleKAP1 articleME1 articleMental Health Research1 articleNMDA antagonists1 articleNevada1 articleOCD1 articlePatient Safety1 articleR-ketamine1 articleRemission1 articleRyan-Haight-Act1 articleS-ketamine1 articleSNRI1 articleSSRI1 articleSchedule III1 articleTMS1 articleabsorption1 articleaccess to care1 articleaddiction1 articleadministration routes1 articlealcohol use disorder1 articleanesthesia1 articleanti-inflammatory1 articleapproval1 articleatai life sciences1 articlebest-practices1 articlebipolar1 articlebipolar depression1 articleblood pressure1 articlebrain circuits1 articlebrain networks1 articlecandidates1 articlechirality1 articlechronic-fatigue-syndrome1 articleclinic access1 articleclinic-standards1 articleclinical care1 articleclinical guidance1 articleclinical management1 articleclinical studies1 articleclinical terms1 articleclinical treatment1 articlecombination therapy1 articlecompanies1 articlecompounding1 articlecompounding pharmacy1 articlecompounding-pharmacy1 articlecontinuous infusion1 articlecontrolled-substance1 articlecredentials1 articlecrisis intervention1 articlecytokines1 articledefinitions1 articledeprescribing1 articledepression-treatment1 articledevelopments1 articlediagnosis1 articledirect-to-consumer1 articledose optimization1 articledrug development1 articledrug-interactions1 articleduration1 articleeffects1 articleelectroconvulsive-therapy1 articleeligibility1 articleemergency psychiatry1 articleemerging treatments1 articleepigenetics1 articleexcitatory1 articleexcitatory-neurotransmission1 articleexperience1 articlefibromyalgia1 articlefinding treatment1 articlefirst-pass-metabolism1 articlefirst-visit1 articlegene-expression1 articlegetting-started1 articleglobal1 articleglutamatergic-system1 articleguidelines1 articlehealthcare1 articlehearing1 articlehistone-modification1 articleindustry1 articleinfusion1 articleinhibitory1 articleinjection1 articleinpatient1 articleintegration1 articleinternational1 articleinterventional psychiatry1 articleketamine clinic1 articleketamine cost1 articleketamine experience1 articleketamine infusion1 articleketamine policy1 articleketamine regulation1 articleketamine safety1 articleketamine treatment1 articleketamine-assisted therapy1 articleketamine-therapy1 articlelegal1 articlelong-term treatment1 articlelozenges1 articlemaintenance1 articlemajor depression1 articlemedical conference1 articlemental health access1 articlemetabolite1 articlemethods1 articlemicroglia1 articlemindset1 articlemonitoring1 articlemood disorders1 articlenasal ketamine1 articlenausea1 articleneuropathic pain1 articleneurotrophic factor1 articlenew research1 articlenonprofit1 articleobsessive-compulsive disorder1 articleopioid addiction1 articleopioid-receptors1 articleopioid-system1 articleoral ketamine1 articleoutcomes1 articlepalliative-care1 articlepanic disorder1 articlepatient guide1 articlepatient-safety1 articlepediatric1 articlepharmacy1 articlephase III1 articleplain language1 articleprior authorization1 articleprivate clinics1 articleprogram expansion1 articleprotein-synthesis1 articleprotocol1 articleprovider1 articleprovider choice1 articleprovider selection1 articlepsilocybin1 articlepsychedelic medicine1 articlepsychedelic therapy1 articlepsychedelic-therapy1 articlepsychiatric care1 articlepsychoactive effects1 articlepsychotherapy1 articlequality1 articleracemic ketamine1 articleracemic-ketamine1 articleracemic-mixture1 articlerapid-acting antidepressants1 articlereceptor1 articlerectal1 articlerelapse prevention1 articlerepeated use1 articleresearch terms1 articlerisk1 articleroutes-of-administration1 articleschedule-III1 articlescience1 articlescreening1 articlesensitization1 articleserotonin1 articleserotonin-syndrome1 articleset and setting1 articleside-effects1 articlestate law1 articlestereochemistry1 articlesub-anesthetic-dose1 articlesublingual ketamine1 articlesubstance use disorders1 articlesuicide prevention1 articlesupervision1 articlesynaptic-growth1 articletelehealth ketamine1 articletherapeutic framework1 articletherapy1 articletinnitus1 articletolerance1 articletopical1 articletranscranial-magnetic-stimulation1 articletrauma1 articletreatment access1 articletreatment comparison1 articletreatment considerations1 articletreatment environment1 articletreatment-resistant conditions1 articletroches1 article